AI-09 for Frown Lines
What You Need to Know Before You Apply
What is the purpose of this trial?
Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.
Are You a Good Fit for This Trial?
This trial is for adults aged 20-70 with moderate to severe frown lines who haven't used facial fillers, retinoids, Botox®, or lasers recently. Women must not be pregnant or breastfeeding and use birth control during the study. Participants should be healthy overall without diseases that could affect the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single dose of AI-09 or Vehicle for the treatment of glabellar lines
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- AI-09
Trial Overview
The study is testing AI-09, a ready-to-use liquid injectable Botulinum Toxin, to see if it's effective and safe for treating glabellar (frown) lines compared to a placebo (vehicle). It's in Phase 2 which means they're looking at how well it works and checking its safety.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
AI-09
Vehicle
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eirion Therapeutics Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.